Ruth E. Wager
12Patents
7h-index
13Co-inventors
59Inventor score
Filing activity: May 16, 1998 → May 15, 2014
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US7402312B2 | Antibodies to vascular endothelial growth factor 2 (VEGF-2) | Chemistry; Metallurgy | 106 | Expired |
| US6093382A | Metal complexes derivatized with folate for use in diagnostic and therapeutic applications | Human Necessities | 80 | Expired |
| US7208582B2 | Vascular endothelial growth factor 2 | Emerging Cross-Sectional Technologies | 37 | Expired |
| US7399460B2 | Metal complexes derivatized with folate for use in diagnostic and therapeutic applications | Human Necessities | 29 | Active |
| US6541249B2 | Immortalized human stromal cell lines | Chemistry; Metallurgy | 23 | Expired |
| US6221334A | Metal complexes derivatized with folate for use in diagnostic and therapeutic applications | Human Necessities | 23 | Expired |
| US7850963B2 | Vascular endothelial growth factor 2 | Emerging Cross-Sectional Technologies | 17 | Active |
| US8216569B2 | Vascular endothelial growth factor 2 | Emerging Cross-Sectional Technologies | 2 | Active |
| US7186397B2 | Metal complexes derivatized with folate for use in diagnostic and therapeutic applications | Human Necessities | 2 | Expired |
| US8206708B2 | Vascular endothelial growth factor 2 | Emerging Cross-Sectional Technologies | 2 | Active |
| US8784809B2 | Vascular endothelial growth factor 2 | Emerging Cross-Sectional Technologies | 0 | Active |
| US9403905B2 | Vascular endothelial growth factor 2 | Emerging Cross-Sectional Technologies | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.